Verastem Due Diligence: Cancels Phase II Study and Market Reacts - BrokerBank Securities

by Paul Quintaro, Benzinga Editor
September 30, 2015 8:05 AM | 15 seconds read |
Verastem, Inc. VSTM shares closed at $1.75 yesterday, down slightly after a day where the stock lost 67% of it value. Investors of Verastem, Inc. may want to gain valuable insight by reading or due diligence. Get our report at the link below at no cost.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!